Skip to main content
. Author manuscript; available in PMC: 2009 Jul 15.
Published in final edited form as: Biochem Pharmacol. 2008 May 8;76(2):198–207. doi: 10.1016/j.bcp.2008.05.004

Fig. 4.

Fig. 4

A: Signaling by oncogenic kRas interferes with apoptosis induced by DHCB. A:Apoptosis was determined in HCT116 and Hke-3 cells that were treated with increasing concentrations of DHCB for 24, 48 or 72 hours by PI staining. Error bars were derived from 3 experiments. B: The activation of caspase 9 was determined in cell lysates using antibody that recognizes both full length caspase 9 and cleaved caspase 9, as well as with antibody recognizing specifically cleaved caspase-9.

HHS Vulnerability Disclosure